Literature DB >> 28399646

Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway.

Xiaolong Shui1, Chengwei Zhou1, Wei Lin1, Yang Yu1, Yongzeng Feng1, Jianzhong Kong1.   

Abstract

BACKGROUND: Chondrosarcoma is one of the common malignant histologic tumors, very difficult to treat, but the concrete cause and mechanism have not yet been elucidated. The present study aimed to investigate the functional involvement of BCAR4 in chondrosarcoma and its potentially underlying mechanism. QRT-PCR and western blot were used to determine the expression of BCAR4 and mTOR signaling pathway proteins both in chondrosarcoma tissues and cells. Chondrosarcoma cell proliferation and migration were assessed by MTT assay and transwell migration assay, respectively. The expression vectors were constructed and used to modulate the expression of BCAR4 and mTOR. Chondrosarcoma xenograft mouse model was established by subcutaneous injection with chondrosarcoma cell lines. The tumor volume was monitored to evaluate the effect of BCAR4 on chondrosarcoma cell tumorigenicity. The expressions of BCAR4, p-mTOR and p-P70S6K were up-regulated in chondrosarcoma tissues and cell lines. Moreover, BCAR4 overexpression had significant promoting effect on cell proliferation and migration in chondrosarcoma cells. Furthermore, mTOR signaling pathway was epigenetically activated by BCAR4-induced hyperacetylation of histone H3. We also found that mTOR overexpression abolished the decrease of chondrosarcoma cell proliferation and migration induced by BCAR4 knockdown. In vivo experiments confirmed that BCAR4 overexpression significantly accelerated tumor growth, while the knockdown of BCAR4 significantly inhibited tumor growth. BCAR4 promoted chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway, and thus contributed to chondrosarcoma progression. Impact statement LncRNA BCAR4 promoted chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway, and thus contributed to chondrosarcoma progression.

Entities:  

Keywords:  BCAR4; chondrosarcoma; mTOR signaling pathway; migration; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28399646      PMCID: PMC5444642          DOI: 10.1177/1535370217700735

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  27 in total

Review 1.  Role of lncRNAs in prostate cancer development and progression.

Authors:  Melanie Weiss; Christoph Plass; Clarissa Gerhauser
Journal:  Biol Chem       Date:  2014-11-01       Impact factor: 3.915

2.  Genetic and epigenetic regulation of human lincRNA gene expression.

Authors:  Konstantin Popadin; Maria Gutierrez-Arcelus; Emmanouil T Dermitzakis; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2013-11-21       Impact factor: 11.025

3.  Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis.

Authors:  Wei Xiang; Ting Jiang; Fengjing Guo; Chen Gong; Kaixiang Yang; Yingxing Wu; Xin Huang; Weiting Cheng; Kai Xu
Journal:  Oncol Rep       Date:  2014-07-31       Impact factor: 3.906

Review 4.  The mTOR signaling pathway is an emerging therapeutic target in multiple myeloma.

Authors:  Jie Li; Jingyu Zhu; Biyin Cao; Xinliang Mao
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.

Authors:  Heth R Turnquist; Tina L Sumpter; Allan Tsung; Alan F Zahorchak; Atsunori Nakao; Gerard J Nau; Foo Y Liew; David A Geller; Angus W Thomson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 6.  CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-05-01       Impact factor: 6.831

7.  Rapamycin causes growth arrest and inhibition of invasion in human chondrosarcoma cells.

Authors:  Jian Song; Xiaobo Wang; Jiaxue Zhu; Jun Liu
Journal:  J BUON       Date:  2016 Jan-Feb       Impact factor: 2.533

8.  [Secondary chondrosarcoma: radiopathological correlation].

Authors:  G A Lozano Martínez; J Llauger Rosselló
Journal:  Radiologia       Date:  2014-07-04

9.  Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma.

Authors:  Yasushi Totoki; Akihiko Yoshida; Fumie Hosoda; Hiromi Nakamura; Natsuko Hama; Koichi Ogura; Aki Yoshida; Tomohiro Fujiwara; Yasuhito Arai; Junya Toguchida; Hitoshi Tsuda; Satoru Miyano; Akira Kawai; Tatsuhiro Shibata
Journal:  Genome Res       Date:  2014-07-14       Impact factor: 9.043

10.  Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation.

Authors:  Wenbo Li; Dimple Notani; Qi Ma; Bogdan Tanasa; Esperanza Nunez; Aaron Yun Chen; Daria Merkurjev; Jie Zhang; Kenneth Ohgi; Xiaoyuan Song; Soohwan Oh; Hong-Sook Kim; Christopher K Glass; Michael G Rosenfeld
Journal:  Nature       Date:  2013-06-02       Impact factor: 49.962

View more
  10 in total

1.  Long Non-Coding RNA HULC Promotes Progression of Bone Neoplasms.

Authors:  Tao Zhang; Chun-You Wan; Xiao-Long Mei; Peng Jia; Ming-Jie Wang
Journal:  Med Sci Monit       Date:  2018-08-18

2.  Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.

Authors:  Yang Meng; Yu-Lan Liu; Kai Li; Tao Fu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  Lycopene upregulates ZO-1 and downregulates claudin-1 through autophagy inhibition in the human cutaneous squamous cell carcinoma cell line COLO-16.

Authors:  Suyun Bi; Li Li; Heng Gu; Min Li; Song Xu; Wenbo Bu; Mengli Zhang; Zhihai Zhou; Xu Chen
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

4.  The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers.

Authors:  Chao Tu; Xiaolei Ren; Jieyu He; Chenghao Zhang; Ruiqi Chen; Wanchun Wang; Zhihong Li
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

5.  Long Non-Coding RNA BCAR4 Promotes Growth, Invasion and Tumorigenicity by Targeting miR-2276 to Upregulate MMP7 Expression in Glioma.

Authors:  Zhifeng Wang; Longlong Wang; Zan Liang; Yanguo Xi
Journal:  Onco Targets Ther       Date:  2019-12-12       Impact factor: 4.147

6.  SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2.

Authors:  Fei-Fei Pu; De-Yao Shi; Ting Chen; Yu-Xuan Liu; Bin-Long Zhong; Zhi-Cai Zhang; Wei-Jian Liu; Qiang Wu; Bai-Chuan Wang; Zeng-Wu Shao; Tong-Chuan He; Jian-Xiang Liu
Journal:  Cell Death Dis       Date:  2021-01-11       Impact factor: 8.469

Review 7.  The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets.

Authors:  Jinxin Liu; Guanning Shang
Journal:  Front Cell Dev Biol       Date:  2022-02-16

8.  MicroRNA-486-5p Suppresses Lung Cancer via Downregulating mTOR Signaling In Vitro and In Vivo.

Authors:  Lei Ding; Wu Tian; Hui Zhang; Wanqiu Li; Chunyu Ji; Yuanyuan Wang; Yanli Li
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

9.  LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling.

Authors:  Shurui Ouyang; Xinbin Zheng; Xin Zhou; Zhengquan Chen; Xuefeng Yang; Ming Xie
Journal:  Oncotarget       Date:  2017-10-06

10.  Effect of silencing lncRNATUG1 on rapamycin-induced inhibition of endothelial cell proliferation and migration.

Authors:  Xue Gao; Tao Zhang; Xi-Yun Zeng; Guo-Jian Li; Ling-Juan Du; Zhen-Huan Ma; Jia Wan; Yong Yang
Journal:  Exp Ther Med       Date:  2018-06-26       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.